Showing results (791-800 of 4,698) with videos related to
Sort By:
Pageof 470
Seminars in Oncology|December 1, 1992
Etoposide in the treatment of hormone-refractory advanced carcinoma of the prostateE D Crawford, F Daneshgari, S A MajeskiSeminars in Oncology|December 1, 1992
What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 daysA van der Gaast, M Vlastuin, T C Kok, et al.Seminars in Oncology|February 19, 2004
Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cellsDaniel H Fowler, Michael R Bishop, Ronald E GressSeminars in Oncology|March 26, 2004
Integrating monoclonal antibodies into the management of mantle cell lymphomaNeil L Berinstein, Joy MangelSeminars in Oncology|March 26, 2004
Effective immunochemotherapy for aggressive non-Hodgkin's lymphomaBertrand CoiffierSeminars in Oncology|March 31, 2004
Opportunities and challenges in the development of targeted therapiesGabriel N HortobagyiSeminars in Oncology|March 31, 2004
Therapeutic targeting in the estrogen receptor hormonal pathwayBenita S Katzenellenbogen, Jonna FrasorSeminars in Oncology|March 31, 2004
Cyclooxygenase-2: a potential target in breast cancerDingzhi Wang, Raymond N DuboisSeminars in Oncology|October 22, 2004
Anaplastic astrocytoma: diagnosis, prognosis, and managementSiew Ju See, Mark R GilbertPageof 470